The ODIN secreatariat received 19 funding applications in the first call round.
The applications have now been reviewed by our Project Review Committee and an international Peer Review Panel and the applications nominated for funding will soon be reviewed by our Steering Group.
"I was impressed by the broad scope and high quality of the applications and enjoyed the stringent and well-organized review meetings with AU faculty and industry representatives. It’s also great to see that industry partners seem to have considerable interest in the type of pre-competitive open innovation projects the ODIN initiative supports. This – together with funding that provides a reasonable runway – is essential in order to be able to design and successfully run highly innovative projects in the areas of biomarker and target validation that address real-world problems with state-of-the-art science."
says Georg Duenstl, Associate Research Fellow at LEO Pharma.
We are looking forward to announcing the exciting projects, which will be funded by ODIN. Stay tuned!